Study of Key Electro-acupuncture Technique on Migraine

NCT ID: NCT02580968

Last Updated: 2020-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A random controlled trail to evaluate the efficacy of migraine standard electroacupuncture formula, and to analysis the regulation of the intensity-effects and to observe the peripheral NO, CGRP and NF-кB expression level of migraine patients after electroacupuncture treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

acupuncture group(group A): treated by acupuncture for 20 days, 1 time per day control group(group B): treated by FlunarizineHydrochloride for 20 days, 1 table per day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Migraine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

electro-acupuncture

100hz, 2min. electro-acupoint: LI4(Large Intestine4) with LV3(Liver3).5times a week. lasting for 4 weeks.

Group Type EXPERIMENTAL

electro-acupuncture

Intervention Type DEVICE

electro-acupuncture on acupoints according to the traditional syndrome diagnosis.once per day, for 20 days.

routin medicine

one tablet of flunarizine hydrochloride tablet per day. lasting for 20days

Group Type ACTIVE_COMPARATOR

flunarizine hydrochloride

Intervention Type DRUG

flunarizine hydrochloride ,10mg/day,for 20 days。

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

electro-acupuncture

electro-acupuncture on acupoints according to the traditional syndrome diagnosis.once per day, for 20 days.

Intervention Type DEVICE

flunarizine hydrochloride

flunarizine hydrochloride ,10mg/day,for 20 days。

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

flunarizine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* met the diagnostic criteria for migraine; suffering from migraine attacks; migraine attacks for more than 5 days per month, and lasts for 3 months; voluntarily join this study with informed consents.

Exclusion Criteria

* other systemic, neurological and psychiatric disorders; headache caused by other diseases; not treatment compliance during the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai University of Traditional Chinese Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jian Pei, Ph.D

Role: STUDY_DIRECTOR

Longhua Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Longhua Hospital,Shanghai University of Traditional Chinese Medicine

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

643857003534

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Self-acupuncture for Migraines Feasibility Study
NCT06716944 ENROLLING_BY_INVITATION PHASE1/PHASE2
Acupuncture and Hot Flashes
NCT00217074 TERMINATED PHASE3